Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma
BelgiumStudy on the Effectiveness of FOLFOX and Panitumumab for Patients with Metastatic Colorectal Cancer Without RAS Mutation
BelgiumStudy of Osimertinib for Patients with EGFR-Mutated Non-Small Cell Lung Cancer
LithuaniaStudy of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors
BulgariaStudy of BDC-1001 and Nivolumab for Patients with Advanced HER2-Positive Solid Tumors
FranceStudy of Monalizumab and Volrustomig for Patients with MSI and/or dMMR Metastatic Cancer
FranceStudy of catequentinib (AL3818) combined with platinum chemotherapy for patients with recurrent or metastatic ovarian, fallopian tube, or primary peritoneal cancer
ItalyStudy on Dacarbazine, Pembrolizumab, Nivolumab, and Ipilimumab for Patients with Unresectable or Metastatic Melanoma Resistant to Immunotherapy
GermanyStudy of drug interactions between enzalutamide, morphine and edoxaban in patients with prostate cancer
The NetherlandsStudy on Sentinel Lymph Node Mapping Using Gallium-68 Chloride and Tilmanocept in Patients with High-Risk Endometrial Cancer
The NetherlandsStudy of Trifluridine and Tipiracil in Patients with ER-Positive, HER2-Negative Advanced Breast Cancer After Chemotherapy
The NetherlandsStudy of L19IL2 and L19TNF for Patients with Advanced Basal Cell Carcinoma or Cutaneous Squamous Cell Carcinoma Not Eligible for Surgery or Radiation
GermanyThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
